1) KIRKLAND & ELLIS
KIRKLAND M&A UPDATE
July 28, 2015
Expect the Unexpected – Foreign Antitakeover
Regimes
The takeover defenses
available, and sometimes unavailable, to
foreign companies
facing unsolicited or
hostile offers occasionally come as a
surprise and complicate the pursuit or
defense of these bids.
The confluence of a number of overlapping factors – including an uptick in global and cross-border M&A
activity, a resurgence in unsolicited takeover offers, the continued flow of tax inversion transactions, and the
growth of activism in non-U.S. markets – means that U.S. companies and investors are more often facing
unfamiliar takeover (and antitakeover) regimes as they evaluate and pursue offers for foreign targets. While
experienced dealmakers are often well-versed in the nuances of friendly transactions with a foreign seller, the
defenses available, and sometimes unavailable, to foreign companies facing unsolicited or hostile offers occasionally come as a surprise and complicate the pursuit or defense of these bids.
While a comprehensive survey of antitakeover regimes in various foreign jurisdictions is well beyond the scope of
this Update, it is instructive to highlight a number of examples where the regime – mandatory or permissive –
departs significantly from U.S. practices, even in countries with well-developed legal systems and capital markets.
****
In a number of jurisdictions, the applicable takeover rules can be seen to facilitate, or even encourage, offerors
in taking rejected overtures to the public shareholders:
Poison Pills
While the poison pill is a well-established mainstay of a defense by a U.S. target against a hostile bid, serving
primarily to force the bidder to engage with the board of the target, such a defense is not permitted in many
jurisdictions, including the United Kingdom and Ireland (two of the primary destinations for inverting U.S.
companies). In Canada, regulators generally will order a target board to “cease trade” (or lift) a poison pill after
just a few months, based on the principle that the defensive measure is intended only as a short-term respite to
allow the target board to quickly assess the availability of alternatives to the hostile bid. As a result, a hostile
acquirer in these jurisdictions generally has the opportunity to take its offer directly to shareholders without
the board of directors of the target being able to intercede or unduly delay the offer.
Frustrating Actions
The effect of the inability to deploy a poison pill in these (and many other) European jurisdictions is extended
by a corresponding ban on the target taking “frustrating” actions (i.e., acts that would interfere with, or
impact, an outstanding or impending offer), such as buying or selling assets above certain size thresholds, issuing stock, amending contracts, etc., without shareholder approval. Again, the rules are designed to leave the
ultimate decision about the bid in the hands of the public shareholders.
****
Equally, many jurisdictions have rules that either facilitate an aggressive defense or otherwise make it harder
for a hostile bidder to succeed:
Timelines
As compared to the U.S. where hostile bids can linger for many months while financing and regulatory
approvals are obtained and stockholder sentiment is swayed, some countries, especially the United Kingdom
and to a lesser degree Ireland, apply a variety of timeline requirements that force a hostile bidder to proceed,
and attempt to succeed, on a very tight calendar. The so-called “put up or shut up” rules apply maximum time
Attorney Advertising
2) KIRKLAND M&A UPDATE | 2
periods for both the launch and thereafter completion
of a fully-financed (under a “funds certain” regime
which requires unconditional access to the necessary
cash) and largely unconditional offer following any
leak or public announcement of a hostile offer.
Foundation Defenses
Companies incorporated in some European jurisdictions, including the Netherlands and Luxembourg,
have sought to use an independent Stichting (or trust
foundation) to defend against unsolicited offers. The
foundation, controlled by independent trustees and
with a broad statement of purposes including the
preservation of the mission of the target company,
may be issued “golden shares” that seek to enable it,
at least temporarily, to control the voting outcome on
any matter put to target shareholders. Alternatively,
as was the case in the Arcelor/Mittal takeover battle,
targets could try to drop “crown jewel” assets into the
foundation, seeking to put those assets beyond the
control of the bidder even if it succeeds, or outside its
reach to facilitate required antitrust divestitures.
National Interest
If you have any questions
about the matters
addressed in this M&A
Update, please contact
the following Kirkland
author or your regular
Kirkland contact.
Daniel E. Wolf
Kirkland & Ellis LLP
601 Lexington Avenue
New York, NY 10022
http://www.kirkland.com/dwolf
+1 212-446-4884
* The author acknowledges the valuable assistance of our summer
associate, Eli Shalam, in
researching the subject
matter.
While U.S. companies may be familiar with the
CFIUS rules under which the President can block or
put conditions on foreign acquisitions of U.S. targets
if national security concerns are implicated, other
countries have much broader national interest review
regimes that empower government officials to block
acquisitions of domestic companies based on their
views on whether the acquisition is in the overall
national interest. Political or corporate pressure may
be exerted by targets to use these regimes to hamper a
hostile takeover by a foreign buyer. For example, the
Investment Canada Act allows an evaluation of a foreign investment based on an assessment of the overall
“net benefit” to Canada, while Australia’s Foreign
Investment Review Board reviews certain acquisitions
under a “national interest” standard that covers a
broad range of issues including the impact on government policies, employees and creditors, as well as the
identity and nationality of the buyer.
Voting Power
Some continental European countries, like Spain and
France, have various mechanisms that address voting
rights associated with a target’s shares in a manner
that can hamper a hostile takeover. For example, both
Spain and France have regulations that permit a company’s bylaws (on an opt-in basis) to cap the voting
rights exercised by any single shareholder (or group)
regardless of actual ownership percentage, thereby
disincentivizing accumulation of a very large toe-hold
position by a hostile bidder. Under France’s controversial Florange Law (which is subject to opt-out by
shareholder approval), long term (i.e., at least two
years) shareholders are granted double voting rights,
thereby mitigating the voting sway of both toehold
positions and post-announcement purchases by merger arbs.
Reciprocity
A number of European countries have enacted
defense principles predicated on reciprocity of regime
with the country of the hostile bidder. Italy’s “passivity” rule that limits defensive measures that may be
taken by a target without shareholder approval is suspended if the hostile offer is made by an entity that is
not itself subject to equivalent passivity rules.
Similarly, a French company’s articles may provide
that similar “neutrality” rules do not apply if the
takeover regime applicable to the bidder would not
similarly constrain it if it were the target of an unsolicited offer. Given the U.S. rules that give a board
substantial flexibility in defending against a hostile
bid, these reciprocity provisions very well could be
implicated if the bidder is a U.S. company.
****
Both the principles and practices of antitakeover
regimes in foreign countries often differ significantly
from those applicable to a U.S. target. U.S. buyers
pursuing unsolicited offers outside the domestic market are well-advised to understand the legal, cultural
and political environment for hostile bids in the target’s home country, as well as the company-specific
provisions embedded in organizational documents.
Similarly, boards and shareholders of companies reincorporating from the U.S. to foreign jurisdictions,
including in inversion transactions, may be surprised
at the vastly different balance of legal power between
the board and shareholders, as well as unique tactics
and vulnerabilities, which apply in their new home
countries.
This communication is distributed with the understanding that the author, publisher and distributor of this communication are not rendering
legal, accounting, or other professional advice or opinions on specific facts or matters and, accordingly, assume no liability whatsoever in
connection with its use. Pursuant to applicable rules of professional conduct, this communication may constitute Attorney Advertising.
© 2015 Kirkland & Ellis LLP. All rights reserved. www.kirkland.com